{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:17:37Z","timestamp":1789769857602,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"applied Basic Research Project of Liao Ning province","award":["2022JH2\/101300074"],"award-info":[{"award-number":["2022JH2\/101300074"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["LD202119"],"award-info":[{"award-number":["LD202119"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["LD2023019"],"award-info":[{"award-number":["LD2023019"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejrad.2025.112256","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:42:24Z","timestamp":1750171344000},"page":"112256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interpretable combined models for predicting treatment response and hematologic toxicity in locally advanced gastric cancer treated with PD-1 blockade and neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"190","author":[{"given":"Yuze","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-716X","authenticated-orcid":false,"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112256_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2025.112256_b0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejrad.2025.112256_b0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ejrad.2025.112256_b0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.6004\/jnccn.2013.0070","article-title":"Gastric Cancer","volume":"2","author":"Ajani","year":"2013","journal-title":"J. Natl. Comp. Can. Netw."},{"key":"10.1016\/j.ejrad.2025.112256_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ejrad.2025.112256_b0030","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41467-020-19965-6","article-title":"Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer","volume":"11","author":"Sah","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejrad.2025.112256_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12957-022-02725-9","article-title":"Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy","volume":"20","author":"Jiang","year":"2022","journal-title":"World J. Surg. Onc."},{"key":"10.1016\/j.ejrad.2025.112256_b0040","doi-asserted-by":"crossref","first-page":"19633","DOI":"10.1002\/cam4.6597","article-title":"Tumor regression grade combined with post\u2010therapy lymph node status: a novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma","volume":"12","author":"Yin","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejrad.2025.112256_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216726","article-title":"PD-1 regulation in immune homeostasis and immunotherapy","author":"Gao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejrad.2025.112256_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003635","article-title":"Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study","volume":"10","author":"Jiang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejrad.2025.112256_b0055","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"Kang","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","article-title":"Current developments in gastric cancer: from molecular profiling to treatment strategy","volume":"20","author":"Alsina","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2025.112256_b0070","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood.2020009016","article-title":"Hematologic complications of immune checkpoint inhibitors","volume":"139","author":"Kroll","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ejrad.2025.112256_b0075","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/JS9.0000000000000368","article-title":"Toxicities associated with immune checkpoint inhibitors: a systematic study","volume":"109","author":"Kong","year":"2023","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2025.112256_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1200\/JCO.21.01015","article-title":"First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 Study","volume":"40","author":"Lenz","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/s12885-022-10261-8","article-title":"Application of preoperative CT texture analysis in papillary gastric adenocarcinoma","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejrad.2025.112256_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950185","article-title":"Accurate preoperative staging and HER2 status prediction of gastric cancer by the deep learning system based on enhanced computed tomography","volume":"12","author":"Guan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0100","article-title":"Practical nomogram based on comprehensive CT texture analysis to preoperatively predict peritoneal occult metastasis of gastric cancer patients","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2022.04.023","article-title":"CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: a dual-center study","volume":"171","author":"Song","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.acra.2023.10.020","article-title":"Delta radiomics model for the prediction of overall survival and local recurrence in small cell lung cancer patients after chemotherapy","volume":"31","author":"Ding","year":"2024","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2025.112256_b0115","article-title":"CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1471-0528.17285","article-title":"Treatment planning computed tomography radiomics for predicting treatment outcomes and haematological toxicities in locally advanced cervical cancer treated with radiotherapy: a retrospective cohort study","volume":"130","author":"Ren","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.ejrad.2025.112256_b0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ejrad.2025.112256_b0130","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231319","article-title":"The image biomarker standardization initiative: standardized convolutional filters for reproducible radiomics and enhanced clinical insights","volume":"310","author":"Whybra","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112256_b0135","first-page":"1980","article-title":"Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients","volume":"109","author":"Hu","year":"2023","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2025.112256_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101657","article-title":"Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: a single-centre retrospective study","volume":"31","author":"Zhang","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0145","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-20-2980","article-title":"Efficacy of pembrolizumab monotherapy for advanced gastric\/gastroesophageal junction cancer with programmed death ligand 1 combined positive score \u226510","volume":"27","author":"Wainberg","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2025.112256_b0150","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1200\/JCO.23.00170","article-title":"Health-related quality of life with nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric\/gastroesophageal junction cancer or esophageal adenocarcinoma from CheckMate 649","volume":"41","author":"Moehler","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2025.112256_b0155","first-page":"49","article-title":"Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: a radiomics nomogram analysis based on CT images and clinicopathological features","volume":"31","author":"Tan","year":"2023","journal-title":"J. Xray Sci. Technol."},{"issue":"10","key":"10.1016\/j.ejrad.2025.112256_b0160","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.4251\/wjgo.v16.i10.4115","article-title":"Computed tomography-based radiomic model for the prediction of neoadjuvant immunochemotherapy response in patients with advanced gastric cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"World J Gastrointest Oncol."},{"issue":"58","key":"10.1016\/j.ejrad.2025.112256_b0165","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"24","author":"Huang","year":"2023","journal-title":"EClinical Medicine"},{"issue":"86","key":"10.1016\/j.ejrad.2025.112256_b0170","article-title":"Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer","volume":"7","author":"Xiong","year":"2025","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2025.112256_b0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-025-11563-8","article-title":"Short-term intra- and peri-tumoral spatiotemporal CT radiomics for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","author":"Bao","year":"2025","journal-title":"Eur. Radiol."},{"issue":"77","key":"10.1016\/j.ejrad.2025.112256_b0180","article-title":"Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter study","volume":"30","author":"Hou","year":"2024","journal-title":"EClinical Medicine"},{"key":"10.1016\/j.ejrad.2025.112256_b0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11547-023-01617-6","article-title":"Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer","volume":"128","author":"Shen","year":"2023","journal-title":"Radiol. Med."},{"key":"10.1016\/j.ejrad.2025.112256_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1088\/0031-9155\/5\/3\/302","article-title":"The distribution of active bone marrow in the adult","volume":"5","author":"Ellis","year":"1961","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ejrad.2025.112256_b0195","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1002\/cam4.2601","article-title":"The volume of 99m Tc sulfur colloid SPET-defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejrad.2025.112256_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mri.2022.06.007","article-title":"Pelvic bones ADC could help to predict severe hematologic toxicity in patients undergoing concurrent chemoradiotherapy for cervical cancer","volume":"94","author":"Pang","year":"2022","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2025.112256_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109489","article-title":"A radiomics approach for predicting acute hematologic toxicity in patients with cervical or endometrial cancer undergoing external-beam radiotherapy","volume":"182","author":"Le","year":"2023","journal-title":"Radiother. Oncol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25003420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:12:13Z","timestamp":1762308733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25003420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S0720048X25003420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112256","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretable combined models for predicting treatment response and hematologic toxicity in locally advanced gastric cancer treated with PD-1 blockade and neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112256"}}